ArticleCancer immunology research2021

Simultaneous Engagement of Tumor and Stroma Targeting Antibodies by Engineered NK-92 Cells Expressing CD64 Controls Prostate Cancer Growth.

Hallie M Hintz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.